The Economic Burden of Diagnosed Opioid Abuse Among Commercially Insured Individuals

References

• . IOM (Institute of Medicine). Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington, DC: The National Academies Press, 2011
   Google Scholar
• . Jan SA. Patient perspective, complexities, and challenges in managed care. J Manag Care Pharm. 2010;16(1 Suppl B):S22–S25
   PubMed Web of Science ®Google Scholar
• . Glajchen M. Chronic pain: treatment barriers and strategies for clinical practice. J Am Board Fam Pract. 2001;14(3):211–218
   PubMedGoogle Scholar
• . Pizzo PA, Clark NM. Alleviating suffering 101 – pain relief in the United States. N Engl J Med. 2012;366(3):197–199
   PubMed Web of Science ®Google Scholar
• . Gatchel RJ, McGeary DD, McGeary CA, . Interdisciplinary chronic pain management: past, present, and future. Am Psychol. 2014;69(2):119–130
   PubMed Web of Science ®Google Scholar
• . Birnbaum HG, White AG, Schiller M, . Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Med. 2011;12:657–667
   PubMed Web of Science ®Google Scholar
• . Pasquale MK, Joshi AV, Dufour R, . Cost drivers of prescription opioid abuse in commercial and Medicare populations. Pain Pract. 2014;14(3):E116–E125
   PubMed Web of Science ®Google Scholar
• . McAdam-Marx C, Roland CL, Cleveland J, . Costs of opioid abuse and misuse determined from a Medicaid database. J Pain Palliat Care Pharmacother. 2010;24(1):5–18
   PubMedGoogle Scholar
• . Strassels SA. Economic burden of prescription opioid misuse and abuse. J Manag Care Pharm. 2009;15(7):556–562
   PubMed Web of Science ®Google Scholar
• . Birnbaum HG, White AG, Reynolds JL, . Estimated costs of prescription opioid analgesic abuse in the United States in 2001: a societal perspective. Clin J Pain. 2006;22(8):667–676
   PubMed Web of Science ®Google Scholar
• . White AG, Birnbaum HG, Mareva MN, . Direct costs of opioid abuse in an insured population in the United States. J Manag Care Pharm. 2005;11(6):469–479
   PubMedGoogle Scholar
• . Volkow ND, McLellan TA. Curtailing diversion and abuse of opioid analgesics without jeopardizing pain treatment. JAMA. 2011;305(13):1346–1347
   PubMed Web of Science ®Google Scholar
• . Chou R, Fanciullo GJ, Fine PG, ; American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113–130
   PubMed Web of Science ®Google Scholar
• . Trescot AM, Boswell MV, Atluri SL, . Opioid guidelines in the management of chronic non-cancer pain. Pain Physician. 2006;9(1):1–39
   PubMedGoogle Scholar
• . Trescot AM, Helm S, Hansen H, . Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines. Pain Physician. 2008;11 ( 2 Suppl):S5–S62
   PubMed Web of Science ®Google Scholar
• . Katz NP, Adams EH, Benneyan JC, . Foundations of opioid risk management. Clin J Pain. 2007;23(2):103–118
   PubMed Web of Science ®Google Scholar
• . Ruetsch C. Empirical view of opioid dependence. J Manag Care Pharm. 2010;16(1 Suppl B):S9–S13
   PubMed Web of Science ®Google Scholar
• . Substance Abuse and Mental Health Services Administration. Results from the 2012 National Survey on Drug Use and Health: summary of national findings. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2013. http://www.samhsa.gov/data/NSDUH/2012SummNatFindDetTables/NationalFindings/NSDUHresults2012.htm#fig7.3. Accessed November 2013
   Google Scholar
• . Rice JB, Kirson NY, Shei A, . Estimating the costs of opioid abuse and dependence from an employer perspective: a retrospective analysis using administrative claims data [published online ahead of print June 12, 2014]. Appl Health Econ Health Policy. No doi available
   Google Scholar
• . Rice B, Kirson NY, Shei A, . Hidden costs to employers of opioid abuse—healthcare costs, work-loss costs, and prevalence of opioid abuse among commercially-insured beneficiaries. Poster presentation at the 2013 PAINWeek conference; September 4–7, 2013; Las Vegas, NV
   Google Scholar
• . Katz NP, Birnbaum H, Brennan MJ, . Prescription opioid abuse: challenges and opportunities for payers. Am J Manag Care. 2013;19(4):295–302
   PubMed Web of Science ®Google Scholar
• . OptumHealth Reporting and Insights. Optum Inc: Eden Prairie, MN
   Google Scholar
• . Truven Health MarketScan Database. Truven Health Analytics Inc: Ann Arbor, MI
   Google Scholar
• . Rice JB, White AG, Birnbaum HG, . A model to identify patients at risk for prescription opioid abuse, dependence, and misuse. Pain Med. 2012;13:1162–1173
   PubMed Web of Science ®Google Scholar
• . White AG, Birnbaum HG, Schiller M, . Economic impact of opioid abuse, dependence, and misuse. Am J Pharm Benefits. 2011;3(4):e59–e70
   Google Scholar
• . White AG, Birnbaum HG, Rothman DB, . Development of a budget-impact model to quantify potential cost savings from prescription opioids designed to deter abuse or ease of extraction. Appl Health Econ Health Policy. 2009;7(1):61–70
   PubMedGoogle Scholar
• . Dufour R, Joshi AV, Pasquale MK, . The prevalence of diagnosed opioid abuse in commercial and Medicare managed care populations [published online ahead of print December 1, 2013]. Pain Pract. 2014;14(3):E106–E115. doi:10.1111/papr.12148
   PubMed Web of Science ®Google Scholar
• . Rossiter LF, Kirson NY, Shei A, . Medical cost savings associated with an extended-release opioid with abuse-deterrent technology in the US. J Med Econ. 2014;17(4):279–287
   PubMedGoogle Scholar
• . Michna E, Kirson NY, Shei A, . Use of prescription opioids with abuse-deterrent technology to address opioid abuse [published online ahead of print April 24, 2014]. Curr Med Res Opin. No doi available
   Google Scholar